Home Tags Posts tagged with "health"
Tag:

health

Entertainment

Princess Catherine Completes National Three Peaks Challenge to Support Royal Marsden Cancer Charity

by Elena Rossi
written by Elena Rossi

LONDON –

Princess Catherine of Wales has completed the National Three Peaks Challenge to raise funds for The Royal Marsden Cancer Charity.

The completion of the physical challenge signifies the Princess’s continued reintegration into public duties and her focus on institutional healthcare support following a period of medical absence.

The National Three Peaks Challenge requires participants to climb the tallest mountains in Scotland, England, and Wales-Ben Nevis, Scafell Pike, and Snowdon/Yr Wyddfa, respectively-within a 24-hour period.

Source: Instagram / @princeandprincessofwales (Source: Supplied)

In photographs shared via social media in early July 2026, Catherine was pictured reuniting with Prince William, Prince George, Princess Charlotte, and Prince Louis following the completion of the challenge in Wales. The celebration was also attended by Carole and Michael Middleton, James Middleton, and the family’s golden retriever, underscoring the personal and family dimension of what had been a highly public undertaking.

Royal Marsden Fundraising and Institutional Link

The fundraising effort supports The Royal Marsden Hospital, the specialist cancer centre where Catherine received part of her treatment and for which she serves as patron. The hospital is a key component of the United Kingdom’s National Health Service cancer network and operates within the statutory framework of the National Health Service Act 2006, which underpins the provision of publicly funded healthcare in England.

“This time last week, completing the National Three Peaks Challenge,” Catherine wrote in the post’s caption. “A huge thank you to everybody who has supported The Royal Marsden Cancer Charity.”

Catherine has previously stated that the challenge was a way to “explore life beyond diagnosis” and a means of giving back to a hospital that “holds great meaning” for her. Her long-standing association with the institution has included regular visits, meetings with clinicians and researchers, and support for its role in advancing cancer trials and treatment pathways across the NHS.

The Royal Marsden’s research and clinical work feed into national standards for cancer care, helping shape how treatment guidelines are implemented in hospitals across the country. By attaching a high-profile fundraising effort to the charity, the Princess is effectively amplifying public attention and philanthropic support for services that sit alongside, and help to extend, core NHS provision.

The challenge also sits within a broader pattern of royal charitable activity, carried out under the constitutional principle of a politically neutral monarchy. While the Royal Family does not set health policy, its patronages and public engagements are designed to support existing institutions and priorities set by government and Parliament. In this case, the focus on cancer care dovetails with ongoing efforts to improve early diagnosis, patient support, and research funding within the national health system.

Medical Timeline and Public Return

The Princess of Wales disclosed her cancer diagnosis in 2024 and announced she was in remission earlier in 2026. During her treatment, she stepped back from royal engagements, in line with Palace practice that senior royals withdraw from public-facing duties while undergoing significant medical care.

Earlier this year, Catherine shared a message regarding her experience with the disease, noting that there were moments of “fear of exhaustion” alongside moments of “strength, kindness, and profound connection”. The statement, released through official channels, was interpreted by cancer charities and patient groups as an important contribution to reducing stigma and encouraging earlier engagement with screening and support services.

Following her remission announcement, she has since resumed her public duties, gradually increasing the pace and visibility of her programme, with an emphasis on health, early childhood and mental wellbeing. Palace aides have framed this as a “managed return” designed to balance medical advice with the expectations placed on a future Queen Consort under the UK’s uncodified constitutional monarchy, in which the Royal Family undertakes public engagements in support of the state and civil society.

Status: Returned to official public duties, with recent engagements including physically demanding charity events such as the Three Peaks and hospital-linked visits that align with her portfolio of patronages and the wider public health agenda.

0 comments
0 FacebookTwitterPinterestEmail
Health

Integrating Rehabilitation and Exercise as Essential Components of Cancer Recovery Care

by Claire Donovan
written by Claire Donovan

The transition from acute cancer treatment to long-term recovery is increasingly being viewed not as a passive phase of healing, but as a critical clinical window. Oncology specialists are advocating for a systemic shift in healthcare delivery, pushing for rehabilitation and guided exercise to be integrated as standard, funded components of cancer care pathways rather than optional supplements.

This movement toward “prehabilitation” and active recovery is driven by evidence that structured physical activity mitigates the debilitating side effects of chemotherapy and radiation, such as muscle atrophy, chronic fatigue, and cognitive impairment. Dr Rosalie Stephens notes that several studies showed structured exercise “helps with how people cope with treatment… their mental health and importantly, how likely they are to survive cancer”.

Clinical Impact of Structured Rehabilitation

The integration of exercise into oncology is not merely about quality of life; it is linked to tangible clinical outcomes. Data from international trials underscore the efficacy of rehabilitation in reducing disease recurrence and improving longevity, particularly in gastrointestinal cancers.

Outcome Measure Impact of Post-Treatment Rehab Exercise (Colon Cancer)
Cancer Recurrence 28% reduction in likelihood of return
Patient Survival Rate 37% increase in survival

Those figures sit against a backdrop in which cancer remains one of the leading causes of death globally and is increasingly managed as a chronic condition rather than a single acute episode of illness. International cancer agencies now describe survivorship as a distinct phase of care, with physical and cognitive rehabilitation recognised as key to restoring function and reducing long-term disability.

Beyond the statistics, the psychological benefits of guided movement are significant. For many patients, the recovery process is isolating. Diane Robertson, who is in recovery after receiving a diagnosis 18 months ago, described the impact of specialized classes as “life-changing”.

For Robertson, the social and supervised nature of the program provided a level of security that solo exercise could not offer. “I’m a paddleboard queen,” Robertson said. “So being in the group with a physio and with a trained person who actually was able to monitor what I’m doing and to get out and be on the board was just an absolute treat.”

Oncology physiotherapist Kirsten Rose. (Source: 1News)

“You don’t need to explain, you don’t need to talk about your treatment or your disease,” she said, highlighting the psychosocial value of peer-supported recovery and the relief many patients feel in a space designed specifically for people living with and beyond cancer.

Systemic Barriers to Access

Despite the growing clinical consensus, there is a significant disconnect between what specialists recommend and the actual public health infrastructure available to patients. Guided rehabilitation is often treated as a lifestyle extra rather than a medical necessity, leaving a structural gap in the continuum of care that begins at diagnosis and can extend for years after treatment ends.

The current limitations in the healthcare system include:

  • Funding Gaps: A lack of dedicated public subsidies or insurance coverage for oncology-specific physiotherapy and exercise programs, even when prescribed by clinicians.
  • Capacity Constraints: Prolonged waitlists for funded physiotherapy services, meaning patients may miss the period when rehabilitation has the greatest impact.
  • Restrictive Eligibility: Narrow criteria that exclude a vast number of cancer survivors from receiving guided support, particularly those who do not fit traditional definitions of disability.
  • Inequity of Access: A reliance on a patient’s ability to self-fund, navigate complex referral systems or advocate for their own care, entrenching disparities for lower-income and rural patients.

Because of these barriers, non-profit organizations like the Cancer Rehabilitation Foundation have stepped in to provide necessary services that would otherwise fall between the cracks. These programs accommodate a “really wide range of ability”, from those “building themselves up from scratch, all the way through to people who maybe are feeling better or they’re further down the track”, as oncology physiotherapist Kirsten Rose explained.

Diane Robertson.

Diane Robertson. (Source: 1News)

Rose observed that the impact is not just physical, noting that participants often have “such a lift in their whole presence” after attending the classes, as confidence, social connection and a sense of control begin to return.

Regulatory and Policy Implications

The reliance on charitable organizations to provide what clinicians consider core rehabilitation highlights a failure in healthcare workforce planning and funding allocation. In most health systems, oncology is tightly governed by national cancer control plans and service specifications, yet rehabilitation and exercise prescriptions frequently sit outside mandated benefits, leaving responsibility to overstretched hospitals and community groups.

Lou James, founder of the Cancer Rehabilitation Foundation, indicated that the absence of a standardized framework is a point of significant frustration for patients. James said people were often “really shocked to learn that the rehabilitation part of cancer is not a standard part of care, nor is it funded”.

“So, unless you can advocate for yourself, unless you can pay yourself, you miss out,” James added.

A person lifting weights as part of a cancer rehabilitation class.

A person lifting weights as part of a cancer rehabilitation class. (Source: 1News)

As demand surges-with referrals to the foundation’s programme increasing by more than 50% last year-the call for government intervention has grown. Health Minister Simeon Brown has stated that he expects patients to access required care in a timely manner and is currently seeking further information on the issue, amid wider debates about how far public health systems should go in formally recognising and funding survivorship services.

For clinicians, the goal is to move beyond the “acute phase” mentality that frames success as the end of chemotherapy or surgery. Instead, they argue that cancer care plans should routinely include individually prescribed, supervised exercise and rehabilitation, tracked and reviewed in the same way as drug regimens. “We need to see prescribed exercise as a medicine, as an important health intervention and not as a luxury,” Dr Stephens said.

0 comments
0 FacebookTwitterPinterestEmail
Entertainment

Lorde Reveals PMDD Diagnosis and Eating Disorder Recovery During Virgin Album Production

by Elena Rossi
written by Elena Rossi

AUCKLAND –

Lorde, the New Zealand recording artist, has disclosed a diagnosis of premenstrual dysphoric disorder (PMDD) and a period of recovery from an eating disorder during the production of her latest album, Virgin.

The disclosure, delivered in a long-form letter to fans, accompanies the release of a collection of demo and skeleton versions of album tracks on the streaming platform untitled.stream. The publication comes nearly one year after the initial release of Virgin, which marked her first studio album since 2021 and has been widely read as a candid document of her mid-20s.

The transparency regarding these health challenges highlights the physiological and psychological pressures inherent in the recording and promotion cycles of global music artists, and underscores the growing expectation that major labels and management companies reflect contemporary mental-health and workplace standards set out in instruments such as the International Labour Organization’s core conventions.

Health Disclosures and Medical Diagnosis

In her letter, the singer detailed her recovery from what she described as a “brief but long gestating” eating disorder. She noted that during the recording process, she worked on her relationship with food and deleted the calorie-tracking application MyFitnessPal.

“The week we started what would become Shapeshifter and What Was That I was working on believing that breakfast wasn’t a negotiation. I made myself drink a smoothie every morning, went to work when I wanted to run away, kept trying, one foot in front of the other.”

Additionally, the artist revealed a diagnosis of PMDD, a severe form of premenstrual syndrome characterized by significant mood disturbances that can interfere with daily functioning. The diagnosis followed observations from a friend who noticed the artist falling into intense depression coinciding with her menstrual cycle.

In a postscript, the singer stated she had researched burnout symptoms and is currently taking a selective serotonin reuptake inhibitor (SSRI), a class of antidepressant medication regulated in most markets under national medicines and pharmacovigilance frameworks.

Lorde’s decision to make these disclosures in her own words, rather than via a management statement, aligns with a broader shift in how public figures communicate health information, balancing privacy with the public interest in honest discussion of mental health and reproductive health.

Archival Content and Production Process

The release of the demo tracks on untitled.stream is intended to serve as a non-traditional behind-the-scenes collection, rather than a conventional deluxe reissue. The artist stated that the archival release was meant to be “realer, funnier, more revealing of crookedness and slant” than standard promotional materials that typically surface late in an album cycle.

Rather than focusing on the polished final product, she described the collection as “celebratory of the way of travelling, the repetitions, the journey” – a rare invitation into the iterative process usually concealed by major-label release strategies.

Regarding the emotional toll of the project, she wrote that the creation of Virgin felt like “a total gift” and an act of self-liberation. She added, “I had the sense that I was setting myself free, building a holy site,” and noted that she “concentrated on singing to myself the way I needed to be sung to.”

The artist also acknowledged the difficulty of speaking publicly about the project following its launch, describing the experience as “raw and exposing in a new way.” Her comments land at a time when touring, promotional demands and online scrutiny are under renewed examination by industry bodies and governments reviewing working conditions in the cultural and creative sectors.

Cover Art and Visual Documentation

The imagery for the album cover consists of X-ray images captured at a medical facility on March 2, 2024. The artist noted she was wearing jewelry from both of her grandmothers during the session, framing the shoot as both clinical and deeply personal.

The singer described her mental state during the shoot as “insane, off the map,” stating that she feared the X-ray machine would “reveal an ugliness and wrongness that went all the way to the bone.”

The shoot was conducted by photographer Eric Wrenn. According to the letter, Wrenn assisted in easing her anxiety, telling her, “it will be perfect, it’s a picture of you, any way you are today is perfect and right.”

The highly medicalized aesthetic of the cover, combined with her disclosures about PMDD, burnout and disordered eating, places Virgin squarely inside a contemporary wave of pop albums that use diagnostic language and hospital imagery to interrogate health systems, treatment pathways and how bodies-particularly women’s bodies-are scrutinised.

The cover of Virgin – Lorde has revealed the X-ray images were taken at a medical facility with her wearing both her grandmothers’ jewellery during the shoot. (Source: Supplied)

Where to get help.

Where to get help. (Source: 1News)

The demo and skeleton tracks are currently available via the untitled.stream platform, alongside the studio version of Virgin. For readers seeking broader context on media and mental health, guidance from bodies such as the World Health Organization’s mental health frameworks continues to shape how institutions, employers and the creative industries respond to disclosures like Lorde’s.

0 comments
0 FacebookTwitterPinterestEmail
World

Tragic Double Bereavement in Stoke-on-Trent as Brothers Die Days Apart from Rare Medical Crises

by Claire Donovan
written by Claire Donovan

STOKE-ON-TRENT – A community in the United Kingdom is grappling with a rare and devastating medical synchronicity after two brothers died within four days of each other, leaving a family to face a double bereavement in less than a week.

The deaths of Dave Rogers, 37, and Chris Rogers, 42, represent a catastrophic convergence of unrelated medical crises-a neurological emergency and a systemic organ failure-that underscores the volatility of sudden adult health collapses. While the events occurred locally in Hanley, the case highlights the precarious nature of critical care outcomes and the psychological toll of compounding grief in a health system already under pressure.

Dave Rogers died on June 15 following a sudden cerebral event. His brother, Chris, passed away on June 19, while battling a prolonged and complex internal illness.

The tragedy began when Dave, who had appeared healthy to those around him, suffered a ruptured brain aneurysm. Aneurysms-weakened areas in an artery wall-can remain asymptomatic for years until a rupture causes a subarachnoid hemorrhage, often resulting in rapid neurological decline and leaving clinicians with only minutes to make life-preserving decisions.

Claire Louise-Meigh, the partner of Chris Rogers, described the suddenness of the event to local reporters.

“Dave had an aneurysm out of nowhere,” Meigh said. “We were having a laugh and a joke with him. Then he just stopped, paused, and dropped. His face drooped and his pupil blew. A blood vessel had burst in his brain.”

Medical teams performed a 13-hour surgical intervention in an attempt to stabilize the 37-year-old, reflecting the intensity of specialist neurosurgical care that such cases demand within England’s National Health Service. Despite the effort, Dave was declared brain dead shortly after emerging from surgery.

As the family dealt with Dave’s collapse, Chris Rogers was simultaneously fighting a deteriorating condition involving multi-organ dysfunction.

The clinical progression described by the family suggests a cycle of hepatic and renal failure. Initial scans revealed damage to Chris’ liver, which failed to filter toxins from the bloodstream, subsequently placing an unsustainable load on the kidneys. This systemic failure led to severe edema-the accumulation of fluid in the interstitial spaces of the body.

“It all started about six months ago,” Meigh said. “A scan revealed part of Chris’ liver was damaged. They said it would regenerate over time. He was getting bad infections because his liver wasn’t filtering any of the toxins out of his blood. That ended up damaging his kidneys. Because they were both knackered, his body couldn’t get rid stuff like it needed to. It was slowly poisoning him.”

The resulting fluid buildup reached critical levels, affecting his limbs and thoracic cavity, which compromised his respiratory function.

“Then he started getting really bad problems with excess fluid in his body. It was building up in his legs, his arms, his stomach, and his chest. It was everywhere. He started struggling to breathe,” Meigh said.

Despite a brief window of perceived clinical improvement, Chris died less than 24 hours after medical staff suggested his liver was beginning to heal.

“Chris died shouting out for his brother. He was never allowed to see his little brother before he passed away, because he was too ill. They never got to say goodbye. I think that just made Chris give up.”

The proximity of the deaths has left the immediate family in a state of acute trauma. The brothers, who resided in the same flats complex in Hanley, were described as close-knit and central to their social circle.

“There was only four days between them. It’s just devastating,” Meigh said. “How does that even happen? I’ve never experienced a week filled with loss like this before. It’s just surreal. They both seemed fine a few weeks ago and we were all enjoying our normal lives. Now they’ve both just gone in the blink of an eye.”

The emotional impact extends to their parents and older sibling, with Meigh noting that their mother is “absolutely beside herself” and their father remains unable to socialize due to the raw nature of the loss.

The brothers were known for their humor and a playful relationship that defined their bond.

“The pair of them were amazing. They got on like a house on fire. They were so funny, it was unreal. They were forever playing tricks on each other,” Meigh said. “I lived with Chris, and Dave lived in the flat above us. We used to shout up at him and he’d shout back down at us. We had some right laughs.”

Beyond the immediate human toll, the case touches on wider questions of how families interact with the health and welfare systems after sudden loss. In England, bereaved relatives navigating hospital processes, death certification and post-mortem decisions do so under the framework of the Coroners and Justice Act 2009, which governs investigations into sudden and unexplained deaths and sets out how the state balances clinical judgment, legal procedure and the rights of families.

The family is currently organizing a joint funeral service for the two men. To manage the sudden financial burden associated with two concurrent burials, a GoFundMe campaign has been established to solicit public support-a step that reflects a broader trend of UK families turning to crowdfunding to bridge gaps between emotional need and the practical realities of funeral costs. For those affected, guidance and pastoral support are also available through NHS-endorsed bereavement services such as those signposted by NHS bereavement care resources.

The family continues to make funeral arrangements as the community processes the loss, with friends and neighbours in Hanley expected to play a prominent role in supporting the grieving parents and surviving sibling in the weeks ahead.

0 comments
0 FacebookTwitterPinterestEmail
Health

Ebola Outbreak in Eastern DRC: Current Case Loads and Transmission Challenges

by Claire Donovan
written by Claire Donovan

Regional Transmission and Current Case Loads

The Democratic Republic of the Congo is currently managing a significant escalation in Ebola Virus Disease (EVD) cases, with the eastern region facing the heaviest burden. Recent data from the Ministry of Communications and Media indicates a critical point in the outbreak’s trajectory, characterized by a substantial number of active infections and a concerning fatality rate for a virus that already carries a reputation for severe hemorrhagic illness and rapid clinical deterioration.

The current epidemiological status of the outbreak is summarized below, illustrating both the scale of transmission and the pressure on frontline services:

Metric Value
Confirmed Cases 1,118
Total Deaths 291
Recoveries 122
Patients Under Care 408
Case Fatality Rate 26%
Suspected Cases 138
Contact Follow-up Rate 77.1%

These figures point to an outbreak that is still very much active: more than a third of confirmed patients remain under care, and the current case fatality rate is high enough to alarm public health authorities, even if it sits below the deadliest historical Ebola epidemics. For policymakers in Kinshasa and provincial capitals, the combination of a sizeable caseload and a large pool of suspected infections complicates decisions on resource allocation, movement restrictions and the protection of already fragile health services.

While the Ituri province remains the primary epicenter of the transmission, there are signs of stabilization in other areas. South Kivu has reported no new transmissions since May 26, though health authorities maintain active surveillance and contact tracing to prevent a resurgence. Officials caution that apparent stability can quickly reverse if surveillance weakens or if population movements from affected zones are not closely monitored.

Epidemiological Surveillance and Containment Gaps

The ability to curb EVD depends heavily on the speed of detection, the rigor of contact tracing and the consistent application of infection-prevention protocols in clinics and community settings. A contact follow-up rate of 77.1% suggests a material gap in the surveillance chain, as public health standards typically require near-universal coverage to effectively break the chain of transmission and cut off secondary clusters.

In volatile regions like eastern DRC, maintaining this level of surveillance is often complicated by infrastructure deficits, insecurity and community mistrust, which can hinder the movement of health workers, the reporting of new symptoms and the safe management of burials. These conditions mean that even well-designed response plans can fail in execution, forcing authorities to constantly recalibrate between what is epidemiologically required and what is operationally feasible on the ground.

The presence of 138 suspected cases indicates a continuing pipeline of potential infections that require rapid laboratory confirmation. Delays in testing or the inability to transport samples from remote or conflict-affected areas often lead to community transmission before isolation protocols can be implemented. For national and provincial decision-makers, that lag time is crucial: it shapes whether they can rely on targeted, ring-fenced interventions or must contemplate broader measures that carry significant social and economic costs.

Institutional Response and Global Risk Assessment

The scale of the current outbreak has put significant pressure on the DRC’s healthcare infrastructure, which is already stretched by recurring epidemics and chronic underinvestment. Despite the deployment of response measures, the gap between the speed of the virus’s spread and the institutional capacity to contain it remains a primary concern for health authorities and international partners.

World Health Organization Director-General Tedros Adhanom Ghebreyesus addressed the situation during a press briefing in Geneva, noting that while the global risk remains low, the internal situation in the affected region is critical. He warned that “the outbreak is continuing to outpace the response,” a characterization that underscores the stakes not only for public health but also for governance, as authorities are judged on their ability to manage risk, communicate transparently and uphold basic health protections.

At the policy level, the response is framed by the International Health Regulations, the global legal framework that requires countries to detect, report and contain public health emergencies of international concern through timely notification and coordinated action. Within that system, the DRC government must balance domestic priorities with its obligations to alert neighbors and partners, an increasingly sensitive issue as Ebola cases have now been detected outside Africa in recent days.

Addressing the current imbalance between viral spread and response capacity requires not only the scale-up of disease surveillance and laboratory networks but also the integration of therapeutic interventions and ring vaccination strategies around confirmed cases and their contacts. The persistence of the outbreak highlights ongoing challenges in health workforce stability, supply chains and community engagement, as well as the need for robust emergency preparedness frameworks in regions with fragile health systems. For now, efforts continue to focus on strengthening detection capacities and securing predictable financing so that the window for intervention closes before cases move beyond the current epicenter and force a far costlier international response.

0 comments
0 FacebookTwitterPinterestEmail
News

Gender Differences in Sleep Quality Perception and Its Health Implications According to Karolinska Institute Study

by Mark Ellison
written by Mark Ellison

STOCKHOLM – Researchers at the Karolinska Institute have identified a significant discrepancy between how men and women perceive their sleep quality versus the actual physiological data.

The findings suggest that while women are more likely to report disturbed sleep and seek clinical treatment, men often experience worse objective sleep quality but fail to perceive it.

This gap in perception may lead to a critical health risk, as men may overlook sleep disorders that are linked to early mortality, diabetes, and cardiovascular disease.

Physiological Sleep Discrepancies

The study compared 238 randomly selected women and 238 men, who were matched by age and BMI to ensure consistent results.

Participants were monitored in their own homes using electroencephalography (EEG) to measure brain waves, electromyography (EMG) for muscle tension, and electrooculography (EOG) for eye movements. Sleep was scored using internationally accepted criteria for clinical and research practice under the framework of the International Labour Organization’s guidelines on occupational safety and health, which recognize sleep disruption as a risk factor for work-related accidents and long-term illness.

The objective data revealed that women consistently achieved higher sleep quality than their male counterparts across several key metrics:

  • Total Sleep Duration: Women averaged 400 minutes of sleep per night, compared to 382 minutes for men.
  • Sleep Efficiency: Women spent more time asleep while in bed and experienced fewer nighttime awakenings.
  • Sleep Stages: Women recorded more stage three (deep) sleep and less stage one (superficial) sleep.

Researchers noted that, taken together, these indicators point to a pattern in which women’s sleep is biologically more restorative on average, even as they report feeling less well-rested.

The Perception Paradox

Despite the objective data, the study found that women subjectively reported significantly lower sleep quality than men.

The researchers determined that this paradox is driven by how different genders perceive and remember waking up during the night.

When women wake up, they typically remain awake longer-approximately nine minutes per instance, compared to just under seven minutes for men.

Because it generally takes five minutes of wakefulness for a person to remember the event the following morning, women are more likely to recall their awakenings.

This led to a stark difference in how participants estimated their sleep disturbances:

  • Men: Underestimated their number of nighttime awakenings by 72%.
  • Women: Underestimated their number of nighttime awakenings by 37%.

The research team found that when men who experienced only short awakenings (around eight minutes) were removed from the data, the gender difference in subjective sleep quality disappeared. That suggests the gender gap is less about fundamental differences in how sleep is biologically experienced, and more about memory, perception, and how those factors shape what patients tell clinicians.

Age-Related Decline in Men

The data further indicated that objective sleep quality deteriorates more rapidly in men as they age, particularly regarding deep sleep.

Among participants aged 30 to 50, the amount of stage three sleep was similar for both genders, at approximately 70 minutes.

However, for those over the age of 65, a significant gap emerged:

  • Women (65+): Averaged 80 minutes of stage three sleep per night.
  • Men (65+): Averaged 53 minutes of stage three sleep per night.

The researchers adjusted these analyses for variables including smoking, alcohol consumption, and BMI to ensure the results were linked to gender and age rather than lifestyle factors.

As populations age and retirement ages rise across Europe and other high‑income economies, the pattern raises concerns for policymakers about older men’s fitness for work in safety‑critical roles, from transport and logistics to policing and health care. Poor deep sleep has been tied to slower reaction times, impaired judgment, and higher accident risk, all of which carry implications for regulators overseeing working‑time rules and fatigue management.

Clinical and Policy Implications

The institute’s findings suggest that the experience of waking up, rather than the physiological act of sleep itself, heavily influences how rested a person feels.

Because many men are unable to perceive their nighttime awakenings, they may be unaware of sleep problems that impact their overall wellbeing. This mismatch between symptoms and perception can undermine clinical screening, which still relies heavily on patient self‑reporting in many primary care systems.

This lack of awareness may result in men failing to seek medical help for conditions that could otherwise be managed. The results add weight to calls from public health officials for more routine, objective sleep assessments in high‑risk groups, including older men and workers in shift‑based or overnight occupations, as part of national non‑communicable disease strategies under the World Health Organization’s NCD policy framework.

Future research will focus on whether these findings remain consistent over longer study periods and the specific causes behind the accelerated decline of sleep quality in aging men. For health systems, the Karolinska team says the next step is to test whether brief, low‑cost screening tools based on objective sleep measures can be integrated into routine check‑ups-before undetected sleep loss shows up as cardiovascular disease, diabetes, or preventable workplace incidents.

0 comments
0 FacebookTwitterPinterestEmail
Entertainment

Jeremy Clarkson Diagnosed with Aggressive Prostate Cancer Amid Clarkson’s Farm Uncertainty

by Elena Rossi
written by Elena Rossi

LONDON – UK media celebrity Jeremy Clarkson has revealed he has been diagnosed with an aggressive form of prostate cancer.

The announcement was made on air during the latest season of the series Clarkson’s Farm, where the presenter informed his co-stars of the diagnosis. The revelation introduces a period of uncertainty regarding the production timeline for the franchise, as Clarkson stated that at the time of filming, he did not know if he would return for another season.

Clarkson confirmed that the cancer was caught early and that he is currently receiving treatment.

Former Top Gear presenter Jeremy Clarkson reveals shock cancer diagnosis. (Source: BBC)

The disclosure from the former Top Gear presenter, one of the UK’s best-known broadcasters, has prompted an outpouring of support from viewers and public figures. It also shines a fresh spotlight on the burden of prostate cancer in the UK, where it is the most commonly diagnosed cancer in men and a significant focus of national screening and awareness campaigns overseen by the National Health Service.

Clinical Definition of Aggressive Malignancy

In medical terms, a cancer described as “aggressive” is characterized by rapid growth and a higher likelihood of spreading beyond its original site. This classification is utilized by health authorities including the National Cancer Institute in the United States and the Cancer Council Victoria in Australia, and underpins how clinicians discuss risk and treatment options with patients.

Such growth is typically driven by DNA mutations that alter cell behavior, allowing cells to divide uncontrollably or evade natural cell death. For instance, mutations that cause an excessive production of the MYC protein can accelerate the rate of cellular division.

The speed of development in aggressive cancers increases the risk that the disease will reach an advanced stage or spread to other organs before diagnosis. While advanced cancers are significantly more difficult to treat, early detection generally provides viable treatment options and is a core aim of national programmes such as the NHS’s cancer strategy in England.

Treatment Mechanisms and Prostate Cancer Risk

The fast-growing nature of aggressive cancers can sometimes be utilized as a therapeutic vulnerability. Chemotherapy functions by damaging DNA; because cancer cells divide more rapidly than most healthy cells, they are often more susceptible to these agents. In prostate cancer, treatment plans may also include surgery, radiotherapy, hormone therapy and, in some cases, active surveillance, depending on how far the disease has progressed.

A primary example of this is Burkitt lymphoma, a highly aggressive blood cancer involving high levels of MYC protein, which saw high cure rates through intensive chemotherapy as early as the 1960s. Developments in such treatment protocols have informed broader oncology practice and helped shape modern regulatory standards for evaluating new cancer medicines through agencies such as the European Medicines Agency.

Prostate cancer is most prevalent in men over the age of 50. While many forms of the disease are slow-growing and low-risk, aggressive variants require prompt intervention. Medical professionals note that symptoms are not always apparent in the early stages, and existing screening techniques are imperfect. That uncertainty has long informed public health debates over when and how routinely to test, and Clarkson’s disclosure is likely to feed into renewed calls from some campaigners for men in high‑risk groups to speak with their doctors about individual screening options.

Clarkson is currently undergoing treatment. The production status of future seasons of Clarkson’s Farm remains unconfirmed, with broadcasters and producers expected to make scheduling decisions once his medical outlook and recovery timeline become clearer.

0 comments
0 FacebookTwitterPinterestEmail
Health

Ebola Outbreak in Congo Highlights Challenges of Bundibugyo Strain, Healthcare Strain, and Community Impact

by Claire Donovan
written by Claire Donovan

Mourners gathered Friday in Bunia, Congo, to bury a six-month-old girl, the third child to die at a local orphanage amid a challenging effort to contain a regional Ebola outbreak. The ceremony was marked by a stark divide between grieving families and the stringent requirements of epidemiological safety. As a small coffin was lowered into the ground by health workers in full protective gear, the community stood at a distance.

“It’s a feeling of sadness because we have lost one of our own, a daughter of the church,” said Father Innocent Ndogo. “As we have always said, the Lord gives, and the Lord takes away.”

The Diagnostic Gap and Viral Specificity

The current crisis is driven by the Bundibugyo strain of the Ebola virus, a distinction that carries severe implications for clinical management. Unlike the more common Zaire virus, which has benefited from the development of targeted vaccines and therapeutic interventions, the Bundibugyo strain currently has no approved treatment or vaccine. This regulatory and pharmaceutical gap significantly complicates the containment strategy and exposes how unevenly global research and development investments are distributed across Ebola species.

Early delays in identifying the specific strain hindered the initial response. Because diagnostic protocols in the region often prioritize the Zaire strain, the Bundibugyo virus was not immediately tested for, allowing the pathogen to circulate further within the population before specialized countermeasures could be considered. This underscores a systemic vulnerability in rapid-response diagnostics when dealing with less common viral variants in resource-constrained environments, and raises questions for national laboratories and international partners about updating testing algorithms, procurement lists and training.

Epidemiological Impact and Regional Spread

The outbreak is heavily concentrated in the Ituri region, which accounts for more than 90% of all reported cases. However, the virus has demonstrated its capacity for cross-border transmission, moving into the North Kivu and South Kivu provinces and crossing into neighboring Uganda, where border communities are tightly linked by trade, family ties and displacement.

Metric Current Status/Impact
Confirmed Cases 894
Confirmed Deaths 200+
Potential Contacts Under Follow-Up 35,000 suspected
Uganda Transmission 19 cases, 2 deaths
Primary Epicenter Ituri region, Democratic Republic of the Congo

These figures, while evolving, are already large enough to strain provincial surveillance systems. Each suspected contact must be identified, informed and monitored daily, a task that depends on local government capacity, community health workers and the steady flow of national and international funding.

Systemic Infrastructure and Workforce Strain

The response in eastern Congo has been hampered by critical shortages in healthcare infrastructure and personal protective equipment (PPE). Reports from the field indicate that even frontline health workers have lacked the necessary masks and gloves to ensure their own safety, creating a precarious environment where the providers of care are themselves at high risk of infection. In some facilities, basic isolation capacity is limited to a handful of beds, forcing difficult triage decisions and delaying referrals.

Beyond material shortages, the intersection of public health and security has created friction. The response has been militarized at times, leading to clashes between residents and healthcare professionals. This tension is most evident during the implementation of safe burial practices. While essential for preventing post-mortem transmission, the impersonal nature of these protocols often conflicts with local cultural and religious traditions, fueling community resistance and occasionally prompting families to remove bodies before teams arrive.

Alex Lock, a communications officer at the International Federation of Red Cross and Red Crescent Societies, emphasized the human cost of the epidemic. “She was a baby. She had her whole life ahead of her. Unfortunately, she was taken by the disease, a disease that, as you know, is transmitted from one person to another,” Lock said, noting that every statistic in the daily situation reports hides a story as personal as the one unfolding in Bunia.

Public Health Governance and Mitigation

To mitigate the spread of the Bundibugyo strain, health authorities must navigate the complex balance between strict infection control and community engagement. Under the International Health Regulations, the World Health Organization and national governments share responsibility for detecting and containing outbreaks that may pose a cross-border threat, a framework that informs decisions on declaring a public health emergency of international concern and on coordinating travel, trade and resource flows.

The current outbreak, while not as lethal as the 2014 epidemic that claimed over 11,000 lives across West Africa, is three times more severe than the 2000 Bundibugyo-related outbreak in Uganda. This trajectory highlights the urgent need for improved surveillance systems, flexible financing mechanisms and the development of broad-spectrum countermeasures that can address multiple Ebola species simultaneously, rather than relying on a single-strain strategy.

The risk to the 35,000 potential contacts remains a primary concern for Africa’s Centres for Disease Control and Prevention and national health ministries, requiring an intensified focus on contact tracing, cross-border data sharing and the stabilization of the healthcare workforce in conflict-affected zones. As the small grave in Bunia is covered with earth, the question now confronting policymakers in Kinshasa, Kampala and Geneva is whether they can move quickly enough to prevent many more.

0 comments
0 FacebookTwitterPinterestEmail
Business

Gene-Edited Dairy in New Zealand: Consumer Acceptance and Climate-Smart Benefits

by Thomas Weber
written by Thomas Weber

WELLINGTON – New Zealand’s dairy sector is evaluating gene-editing technologies as a strategic hedge against rising temperatures that threaten milk production and livestock welfare.

As heat stress reduces the environmental efficiency of dairy farming, the economic implications are significant for a national economy heavily reliant on dairy exports. The integration of “climate-smart” cattle could secure productivity levels, provided the industry can overcome consumer resistance and navigate a cautious regulatory environment.

Research conducted by scientists from the University of Otago and the University of Auckland indicates that while conventional milk remains the primary consumer choice, there is a viable market path for gene-edited dairy products if pricing and perceived benefits are calibrated carefully.

The study surveyed nearly 1,100 New Zealand consumers to determine the specific trade-offs they would make in a supermarket environment. Participants evaluated hypothetical products based on price, familiarity, and functional benefits, mirroring real-world purchasing conditions rather than abstract opinions.

The choice experiment compared several product categories:

  • Conventional milk
  • Organic milk
  • Standard gene-edited milk
  • Allergy-free gene-edited milk (designed for improved digestibility)
  • Gene-edited milk featuring “COVID-protection” antibodies

The findings show that consumer resistance is not fixed. Acceptance of gene-edited milk increased significantly when the products were priced lower than conventional alternatives, indicating that cost remains a powerful lever even in emerging food technologies.

Direct personal benefits also drove purchasing intent. Allergy-free milk emerged as the most popular gene-edited option, suggesting that consumers prioritize tangible, individual health gains over abstract environmental claims or long-term system-wide benefits.

Conversely, the “COVID-protection” feature met with mixed results, with some participants expressing skepticism or fatigue regarding pandemic-related health messaging and uncertainty over how such claims would be verified or regulated.

New Zealand’s dairy industry, dominated by cooperatives such as Fonterra, operates under strict rules for genetic technologies. Gene editing is currently treated in line with broader genetic modification controls, with approvals governed by the country’s hazard and new-organism legislation and implemented by specialist regulators alongside the Ministry for Primary Industries. However, gene editing is viewed by some researchers as a more precise approach than traditional genetic modification because it can promote or remove traits without necessarily introducing foreign genetic material.

This technical distinction is critical for market positioning and for future policy decisions. The ability to develop cattle that are more heat-tolerant and produce fewer methane emissions aligns with national sustainability targets and the need to maintain export competitiveness in a carbon-constrained global market, where trading partners are increasingly scrutinising on-farm emissions and production methods.

“Our findings suggest there may be a pathway towards greater consumer openness, particularly when innovations deliver direct and meaningful benefits, rather than vague promises of future sustainability,” the researchers conclude.

For dairy companies, the transition to these technologies requires a shift in corporate strategy, moving away from broad sustainability narratives toward transparent, benefit-driven messaging that clearly explains what gene editing is, how it differs from older forms of genetic modification, and how products will be monitored and labelled.

The economic viability of gene-edited dairy will depend on the ability of producers to balance productivity gains with the consumer’s preference for simplicity and familiarity, as well as to comply with any future updates to the regulatory settings that govern novel food technologies.

The regulatory framework overseen by the Ministry for Primary Industries continues to influence how these biotechnologies move from the lab to commercial production, including risk assessments, animal welfare standards, and export certification. Any shift in New Zealand’s stance on gene-edited livestock would likely require formal policy review and public consultation, given the country’s history of tight controls on genetic modification.

Commercial adoption of gene-edited livestock therefore remains contingent on regulatory approval, evolving public attitudes, and the establishment of clear, trustworthy producer-to-consumer labelling standards that can reassure both domestic shoppers and overseas buyers.

0 comments
0 FacebookTwitterPinterestEmail
Health

Invasive Meningococcal Disease: Rapid Progression, Risk Factors, and Prevention Strategies

by Claire Donovan
written by Claire Donovan
Polio vaccine by injection. (credit: SHUTTERSTOCK)

The recent deaths of two young children-a three-year-old at Dana-Dwek Children’s Hospital and a two-year-old at Soroka Medical Center-highlight the devastating speed of invasive meningococcal disease and the limits of even highly advanced pediatric care. While the clinical suspicion in both cases was meningococcemia, the outcomes underscore the extreme virulence of the bacterium when it enters the bloodstream, often bypassing the typical markers of meningitis to trigger rapid systemic collapse. For health authorities, such cases are a stark reminder that surveillance, rapid diagnosis, and vaccination policy are as critical as bedside treatment.

Pathogenesis of Invasive Meningococcal Disease

The causative agent, Neisseria meningitidis, is a bacterium capable of producing two distinct and life-threatening conditions. While meningitis involves the inflammation of the protective membranes covering the brain and spinal cord, meningococcemia is a bloodstream infection of far greater immediate aggression and mortality risk.

In cases of meningococcemia, the bacterium multiplies rapidly within the blood, inciting an intense systemic inflammatory response. This cascade leads to widespread coagulation disorders, a precipitous drop in blood pressure, and multi-organ failure. The progression from initial symptoms to septic shock can occur within hours, leaving a very narrow window for clinical intervention and resuscitation. Even when children arrive promptly at emergency departments, the biological pace of the disease can outstrip the best efforts of clinicians.

Transmission Dynamics and Asymptomatic Carriage

The bacterium is transmitted through respiratory and throat secretions, primarily via close and prolonged contact. This includes activities such as coughing, sneezing, or exposure to saliva in crowded environments. A critical challenge for public health monitoring is the phenomenon of “carriage,” where the bacterium resides in the throat of a healthy individual without causing illness.

These asymptomatic carriers can transmit the pathogen to others. In most instances, the recipient’s immune system manages the bacterium; however, in rare and unpredictable cases, the pathogen breaches the mucosal barrier and enters the bloodstream or the meninges, leading to invasive disease. This silent circulation places a premium on institutional responses-school systems, childcare centers, and hospital infection-control teams must be able to move quickly when a case is confirmed, tracing close contacts and coordinating with local health departments.

Population Risk and Vulnerability

While meningococcal disease can affect any individual regardless of baseline health, certain biological and environmental factors significantly increase the risk of severe outcomes.

Risk Category Contributing Factors
Age-Based Risk Infants, toddlers, adolescents, and young adults, particularly those in transitional settings such as starting daycare, school, or university.
Environmental Factors Living in crowded conditions, such as dormitories, boarding schools, refugee reception centers, or military barracks.
Immunological Deficiencies People without a functioning spleen, those with complement deficiencies, or patients on immunosuppressive drugs.
Other Factors Travelers to endemic regions with higher prevalence of the disease, and close contacts of confirmed cases who have not yet received prophylactic antibiotics.

For ministries of health, education, and defense, these categories are not abstract: they define which dorms, classrooms, and units must be prioritized when rolling out vaccination campaigns or issuing emergency guidance to parents and caregivers.

Clinical Indicators and Early Identification

Early detection is the primary determinant of survival in meningococcal cases. However, initial presentations often mimic common pediatric viral illnesses, which can complicate early triage in emergency departments and community clinics.

  • General Febrile Symptoms: High fever, chills, weakness, drowsiness, muscle aches, and rapid breathing.
  • Pediatric-Specific Signs: In infants and toddlers, indicators may include apathy, refusal to eat, unusual crying, grayish or mottled skin tone, or a general lack of responsiveness.
  • Critical Warning Signs: The appearance of a pinpoint rash or small blood spots (petechiae) that do not disappear when pressure is applied, or a rapidly spreading purplish rash.
  • Meningitis Markers: Severe headache, neck stiffness, confusion, vomiting, and sensitivity to light.

Emergency protocols in many countries now instruct clinicians to treat suspected meningococcal sepsis with immediate broad-spectrum antibiotics and intensive supportive care without waiting for full laboratory confirmation. For parents and primary-care providers, the key message is to seek urgent evaluation when a high fever is accompanied by lethargy, unusual behavior, or a non-blanching rash.

Preventative Frameworks, Vaccine Policy, and Public Responsibility

From a regulatory and public health perspective, the management of meningococcal disease relies heavily on targeted vaccination strategies and clear national guidelines. Many countries base their schedules on the recommendations of the national immunization advisory bodies and governing vaccination frameworks, which determine which age groups and risk categories should routinely receive meningococcal conjugate and serogroup B vaccines.

There is a specific vaccine developed for meningococcal B, designed to mitigate the risk of serious disease from that particular strain, alongside vaccines that target other common serogroups. Public health systems focus on deploying vaccination programs tailored to high-risk groups and specific age cohorts, and on updating those programs when surveillance data show shifts in circulating strains. In outbreak situations-for example, clusters in a university dormitory or a childcare facility-health ministries can authorize emergency vaccination campaigns and post-exposure prophylaxis for close contacts under existing infectious-disease regulations.

Because the disease is relatively rare but carries a high mortality rate, healthcare infrastructure prioritizes rapid diagnostic capabilities, clear communication with parents and educators, and the immediate administration of antibiotics upon suspicion, as the speed of the inflammatory response often outpaces the ability to confirm a diagnosis via culture. Ultimately, the effectiveness of these frameworks depends on implementation: vaccination uptake, adherence to reporting obligations by hospitals and clinics, and the willingness of institutions-from schools to military bases-to act quickly when a single suspected case appears.

0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts